SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/264451"
 

Search: onr:"swepub:oai:gup.ub.gu.se/264451" > High expression of ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response

Arrizabalaga, O. (author)
Moreno-Cugnon, L. (author)
Auzmendi-Iriarte, J. (author)
show more...
Aldaz, P. (author)
de Caceres,, II (author)
Garros-Regulez, L. (author)
Moncho-Amor, V. (author)
Torres-Bayona, S. (author)
Pernia, O. (author)
Pintado-Berninches, L. (author)
Carrasco-Ramirez, P. (author)
Cortes-Sempere, M. (author)
Rosas, R. (author)
Sanchez-Gomez, P. (author)
Ruiz, I. (author)
Carén, Helena, 1979 (author)
Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för patologi,Sahlgrenska Cancer Center,Institute of Biomedicine, Department of Pathology
Pollard, S. (author)
Garcia, I. (author)
Sacido, A. A. (author)
Lovell-Badge, R. (author)
Belda-Iniesta, C. (author)
Sampron, N. (author)
Perona, R. (author)
Matheu, A. (author)
show less...
 (creator_code:org_t)
2017-12-14
2017
English.
In: Oncogenesis. - : Springer Science and Business Media LLC. - 2157-9024. ; 6
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The elucidation of mechanisms involved in resistance to therapies is essential to improve the survival of patients with malignant gliomas. A major feature possessed by glioma cells that may aid their ability to survive therapy and reconstitute tumors is the capacity for self-renewal. We show here that glioma stem cells (GSCs) express low levels of MKP1, a dual-specificity phosphatase, which acts as a negative inhibitor of JNK, ERK1/2, and p38 MAPK, while induction of high levels of MKP1 expression are associated with differentiation of GSC. Notably, we find that high levels of MKP1 correlate with a subset of glioblastoma patients with better prognosis and overall increased survival. Gain of expression studies demonstrated that elevated MKP1 impairs self-renewal and induces differentiation of GSCs while reducing tumorigenesis in vivo. Moreover, we identified that MKP1 is epigenetically regulated and that it mediates the anti-tumor activity of histone deacetylase inhibitors (HDACIs) alone or in combination with temozolomide. In summary, this study identifies MKP1 as a key modulator of the interplay between GSC self-renewal and differentiation and provides evidence that the activation of MKP1, through epigenetic regulation, might be a novel therapeutic strategy to overcome therapy resistance in glioblastoma.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

protein-kinase phosphatase-1
tumor-initiating cells
human
breast-cancer
n-terminal kinase
p38 mapk
temozolomide resistance
human glioblastoma
pivotal role
lung-cancer
activation
Oncology

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view